168 related articles for article (PubMed ID: 33851271)
1. Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma.
Neves JB; Vanaclocha Saiz L; Abu-Ghanem Y; Marchetti M; Tran-Dang MA; El-Sheikh S; Barod R; Beisland C; Capitanio U; Cullen D; Klatte T; Ljungberg B; Mumtaz F; Patki P; Stewart GD; Dabestani S; Tran MGB; Bex A;
World J Urol; 2021 Oct; 39(10):3823-3831. PubMed ID: 33851271
[TBL] [Abstract][Full Text] [Related]
2. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
3. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
[TBL] [Abstract][Full Text] [Related]
4. Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series.
Casuscelli J; Becerra MF; Seier K; Manley BJ; Benfante N; Redzematovic A; Stief CG; Hsieh JJ; Tickoo SK; Reuter VE; Coleman JA; Russo P; Ostrovnaya I; Hakimi AA
Clin Genitourin Cancer; 2019 Oct; 17(5):373-379.e4. PubMed ID: 31326335
[TBL] [Abstract][Full Text] [Related]
5. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
6. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma.
Frank I; Blute ML; Cheville JC; Lohse CM; Weaver AL; Leibovich BC; Zincke H
J Urol; 2003 Dec; 170(6 Pt 1):2225-32. PubMed ID: 14634384
[TBL] [Abstract][Full Text] [Related]
7. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
Pardo P; Rodríguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
[TBL] [Abstract][Full Text] [Related]
9. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
[TBL] [Abstract][Full Text] [Related]
10. Risk-adjusted proposal for >60 months follow up after surgical treatment of organ-confined renal cell carcinoma according to life expectancy.
Frees SK; Kamal MM; Nestler S; Levien PM; Bidnur S; Brenner W; Thomas C; Jaeger W; Thüroff JW; Roos FC
Int J Urol; 2019 Mar; 26(3):385-390. PubMed ID: 30588677
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
12. Impact of Time to Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma.
Shiff B; Breau RH; Patel P; Mallick R; Tanguay S; So A; Lavallée L; Moore R; Rendon R; Kapoor A; Pouliot F; Finelli A; Bhindi B; Lattouf JB; Basappa N; Wood L; Heng D; Bjarnason G; Drachenberg D
J Urol; 2021 Jan; 205(1):78-85. PubMed ID: 32614274
[TBL] [Abstract][Full Text] [Related]
13. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.
Thomas AZ; Adibi M; Borregales LD; Hoang LN; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
J Urol; 2015 Aug; 194(2):316-22. PubMed ID: 25758610
[TBL] [Abstract][Full Text] [Related]
14. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
15. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
[TBL] [Abstract][Full Text] [Related]
16. Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?
Delacroix SE; Chapin BF; Chen JJ; Nogueras-Gonzalez GM; Tamboli P; Matin SF; Wood CG
J Urol; 2011 Oct; 186(4):1236-41. PubMed ID: 21849197
[TBL] [Abstract][Full Text] [Related]
17. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract][Full Text] [Related]
19. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study.
Lee WK; Byun SS; Kim HH; Rha KH; Hwang TK; Sung GT; Lee W; Lim JS; Jeong YB; Kwon TG
Int J Urol; 2010 Nov; 17(11):898-904. PubMed ID: 20969636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]